{"transactions":[{"id":1479136,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:00:07.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":false,"shares":10600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on March 21, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":68800,"derivative":{"exercise_price":14.59,"expiration_date":"2032-03-20","underlying":"Common Stock","underlying_shares":10600},"source":{"system":"sec-edgar","filing":"0001415889-24-016994","document":"form4-06142024_060603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924016994/form4-06142024_060603.xml","form_type":"4"}},{"id":1479135,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-14T22:00:07.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":10600,"price":25,"value":265000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-016994","document":"form4-06142024_060603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924016994/form4-06142024_060603.xml","form_type":"4"}},{"id":1479134,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-14T22:00:07.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":true,"shares":10600,"price":14.59,"value":154654.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."}],"balance_after":10600,"source":{"system":"sec-edgar","filing":"0001415889-24-016994","document":"form4-06142024_060603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924016994/form4-06142024_060603.xml","form_type":"4"}},{"id":1528442,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:18.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":1981,"price":21.015,"value":41630.715,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to E*TRADE Securities LLC's Quicksale Trading Plan elected by the reporting person on July 11, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 1,981 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.972 to $21.12, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-012235","document":"form4-05032024_060504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924012235/form4-05032024_060504.xml","form_type":"4"}},{"id":1549908,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-03T22:00:17.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of this option vested and became exercisable on March 21, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":79400,"derivative":{"exercise_price":14.59,"expiration_date":"2032-03-20","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001415889-24-010139","document":"form4-04032024_060410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010139/form4-04032024_060410.xml","form_type":"4"}},{"id":1549907,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:17.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":1504,"price":29.999,"value":45118.496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.65 to $30.45, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010139","document":"form4-04032024_060410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010139/form4-04032024_060410.xml","form_type":"4"}},{"id":1549906,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:17.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":3796,"price":28.8669,"value":109578.7524,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.475 to $29.24, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001415889-24-010139","document":"form4-04032024_060410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010139/form4-04032024_060410.xml","form_type":"4"}},{"id":1549905,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:17.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":5300,"price":14.59,"value":77327.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."}],"balance_after":5300,"source":{"system":"sec-edgar","filing":"0001415889-24-010139","document":"form4-04032024_060410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010139/form4-04032024_060410.xml","form_type":"4"}},{"id":1566098,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-20T22:00:31.000Z","date":"2024-03-19","kind":"exercise","planned":true,"acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of this option vested and became exercisable on March 21, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":84700,"derivative":{"exercise_price":14.59,"expiration_date":"2032-03-20","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001415889-24-008772","document":"form4-03202024_060317.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008772/form4-03202024_060317.xml","form_type":"4"}},{"id":1566097,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-20T22:00:31.000Z","date":"2024-03-19","kind":"sale","planned":true,"acquired":false,"shares":2764,"price":26.4558,"value":73123.8312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.30 to $26.71, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-008772","document":"form4-03202024_060317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008772/form4-03202024_060317.xml","form_type":"4"}},{"id":1566096,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-20T22:00:31.000Z","date":"2024-03-19","kind":"sale","planned":true,"acquired":false,"shares":2536,"price":25.6779,"value":65119.1544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.255 to $26.125, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2764,"source":{"system":"sec-edgar","filing":"0001415889-24-008772","document":"form4-03202024_060317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008772/form4-03202024_060317.xml","form_type":"4"}},{"id":1566095,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-20T22:00:31.000Z","date":"2024-03-19","kind":"exercise","planned":true,"acquired":true,"shares":5300,"price":14.59,"value":77327.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023."}],"balance_after":5300,"source":{"system":"sec-edgar","filing":"0001415889-24-008772","document":"form4-03202024_060317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008772/form4-03202024_060317.xml","form_type":"4"}},{"id":1672144,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-24T23:00:31.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":66586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 22, 2024."}],"balance_after":66586,"derivative":{"exercise_price":20,"expiration_date":"2034-01-21","underlying":"Common Stock","underlying_shares":66586},"source":{"system":"sec-edgar","filing":"0001415889-24-001776","document":"form4-01242024_060108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924001776/form4-01242024_060108.xml","form_type":"4"}},{"id":1749910,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Common Stock","published_at":"2023-11-03T21:00:23.000Z","date":"2023-11-01","kind":"sale","planned":false,"acquired":false,"shares":970,"price":10.4625,"value":10148.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to E*TRADE Securities LLC's Quicksale Trading Plan elected by the reporting person on July 11, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 970 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.96 to $10.78, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-014774","document":"form4-11032023_051106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923014774/form4-11032023_051106.xml","form_type":"4"}},{"id":1902936,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT, CMC"}}],"security":"Common Stock","published_at":"2023-05-05T22:00:12.000Z","date":"2023-05-03","kind":"sale","planned":false,"acquired":false,"shares":759,"price":20.7897,"value":15779.3823,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to E*TRADE Securities LLC's Quicksale Trading Plan elected by the reporting person on July 11, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 759 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.78 to $20.84, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-007476","document":"form4-05052023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923007476/form4-05052023_060501.xml","form_type":"4"}},{"id":2026599,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT, CMC"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-08T23:10:20.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on March 7, 2023."}],"balance_after":62000,"derivative":{"exercise_price":25.57,"expiration_date":"2033-02-06","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001415889-23-002174","document":"form4-02082023_060211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923002174/form4-02082023_060211.xml","form_type":"4"}},{"id":2125877,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT, CMC"}}],"security":"Common Stock","published_at":"2022-11-03T21:00:10.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":1130,"price":18.89,"value":21345.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to E*TRADE Securities LLC's Quicksale Trading Plan elected by the reporting person on July 11, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 1,130 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-011066","document":"form4-11032022_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011066/form4-11032022_051101.xml","form_type":"4"}},{"id":2320116,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89878,"kind":"person","name":"Verwijs Marinus","position":1,"cik":"0001916553","reported_name":"Verwijs Marinus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, CMC"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-23T11:47:34.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on March 21, 2023, with the remainder vesting in 36 substantially equal monthly installments."}],"balance_after":90000,"derivative":{"exercise_price":14.59,"expiration_date":"2032-03-20","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001493152-22-007499","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000149315222007499/ownership.xml","form_type":"4"}}]}